3.連結財務諸表及び主な注記
(1)連結貸借対照表
|
|
|
|
|
|
|
|
|
|
|
|
(単位:百万円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年3月31日)
|
当連結会計年度
(2026年3月31日)
|
|
資産の部
|
|
|
|
|
流動資産
|
|
|
|
|
|
現金及び預金
|
55,425
|
50,032
|
|
|
|
受取手形
|
4,137
|
5,032
|
|
|
|
売掛金
|
58,975
|
62,535
|
|
|
|
電子記録債権
|
1,529
|
3,244
|
|
|
|
有価証券
|
4,337
|
4,463
|
|
|
|
商品及び製品
|
44,917
|
53,225
|
|
|
|
仕掛品
|
1,397
|
1,412
|
|
|
|
原材料及び貯蔵品
|
25,227
|
29,672
|
|
|
|
未収入金
|
6,639
|
5,751
|
|
|
|
その他
|
4,436
|
4,897
|
|
|
|
貸倒引当金
|
△229
|
△114
|
|
|
|
流動資産合計
|
206,794
|
220,153
|
|
|
固定資産
|
|
|
|
|
|
有形固定資産
|
|
|
|
|
|
|
建物及び構築物(純額)
|
48,231
|
51,976
|
|
|
|
|
機械装置及び運搬具(純額)
|
26,252
|
30,563
|
|
|
|
|
土地
|
9,507
|
9,923
|
|
|
|
|
建設仮勘定
|
21,277
|
23,770
|
|
|
|
|
その他(純額)
|
4,049
|
4,731
|
|
|
|
|
有形固定資産合計
|
109,317
|
120,966
|
|
|
|
無形固定資産
|
|
|
|
|
|
|
のれん
|
640
|
499
|
|
|
|
|
その他
|
3,411
|
3,255
|
|
|
|
|
無形固定資産合計
|
4,051
|
3,755
|
|
|
|
投資その他の資産
|
|
|
|
|
|
|
投資有価証券
|
35,393
|
30,600
|
|
|
|
|
長期貸付金
|
521
|
474
|
|
|
|
|
長期前払費用
|
2,576
|
6,791
|
|
|
|
|
退職給付に係る資産
|
11,032
|
12,285
|
|
|
|
|
繰延税金資産
|
2,092
|
1,796
|
|
|
|
|
その他
|
1,977
|
1,962
|
|
|
|
|
貸倒引当金
|
△49
|
△49
|
|
|
|
|
投資その他の資産合計
|
53,544
|
53,860
|
|
|
|
固定資産合計
|
166,914
|
178,582
|
|
|
資産合計
|
373,708
|
398,736
|
|
|
|
|
|
|
|
|
|
|
|
|
(単位:百万円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年3月31日)
|
当連結会計年度
(2026年3月31日)
|
|
負債の部
|
|
|
|
|
流動負債
|
|
|
|
|
|
支払手形及び買掛金
|
19,869
|
24,225
|
|
|
|
短期借入金
|
7,212
|
11,013
|
|
|
|
未払金
|
18,797
|
16,342
|
|
|
|
未払費用
|
6,490
|
6,611
|
|
|
|
未払法人税等
|
1,492
|
5,588
|
|
|
|
返金負債
|
412
|
106
|
|
|
|
役員賞与引当金
|
195
|
170
|
|
|
|
その他
|
1,136
|
1,070
|
|
|
|
流動負債合計
|
55,606
|
65,128
|
|
|
固定負債
|
|
|
|
|
|
社債
|
14,000
|
14,000
|
|
|
|
長期借入金
|
20,884
|
24,171
|
|
|
|
繰延税金負債
|
10,358
|
10,500
|
|
|
|
役員退職慰労引当金
|
10
|
13
|
|
|
|
退職給付に係る負債
|
434
|
356
|
|
|
|
長期預り金
|
3,311
|
3,227
|
|
|
|
その他
|
582
|
1,234
|
|
|
|
固定負債合計
|
49,581
|
53,503
|
|
|
負債合計
|
105,188
|
118,631
|
|
純資産の部
|
|
|
|
|
株主資本
|
|
|
|
|
|
資本金
|
14,932
|
14,932
|
|
|
|
資本剰余金
|
15,861
|
15,879
|
|
|
|
利益剰余金
|
202,714
|
210,323
|
|
|
|
自己株式
|
△6,527
|
△16,503
|
|
|
|
株主資本合計
|
226,981
|
224,632
|
|
|
その他の包括利益累計額
|
|
|
|
|
|
その他有価証券評価差額金
|
12,374
|
11,340
|
|
|
|
為替換算調整勘定
|
23,422
|
37,847
|
|
|
|
退職給付に係る調整累計額
|
4,749
|
5,181
|
|
|
|
その他の包括利益累計額合計
|
40,546
|
54,369
|
|
|
非支配株主持分
|
992
|
1,102
|
|
|
純資産合計
|
268,520
|
280,104
|
|
負債純資産合計
|
373,708
|
398,736
|
E00836
42720
日本化薬株式会社
NIPPON KAYAKU CO.,LTD.
通期第1号参考様式 [日本基準](連結)
Japan GAAP
true
cte
cte
2025-04-01
2026-03-31
FY
2026-03-31
2024-04-01
2025-03-31
2025-03-31
1
false
false
false
42720
2026-05-12
42720
2025-04-01
2026-03-31
42720
2025-04-01
2026-03-31
jppfs_cor:CapitalStockMember
42720
2025-04-01
2026-03-31
jppfs_cor:CapitalSurplusMember
42720
2025-04-01
2026-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
42720
2025-04-01
2026-03-31
jppfs_cor:NonControllingInterestsMember
42720
2025-04-01
2026-03-31
jpcrp_cor:ReconcilingItemsMember
42720
2025-04-01
2026-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
42720
2025-04-01
2026-03-31
jpcrp_cor:ReportableSegmentsMember
42720
2025-04-01
2026-03-31
jppfs_cor:RetainedEarningsMember
42720
2025-04-01
2026-03-31
jppfs_cor:ShareholdersEquityMember
42720
2025-04-01
2026-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
42720
2025-04-01
2026-03-31
jppfs_cor:TreasuryStockMember
42720
2025-04-01
2026-03-31
tse-acedjpfr-42720:FineChemicalsBusinessUnitReportableSegmentMember
42720
2025-04-01
2026-03-31
tse-acedjpfr-42720:LifeScienceBusinessUnitReportableSegmentMember
42720
2025-04-01
2026-03-31
tse-acedjpfr-42720:MobilityAndImagingBusinessUnitReportableSegmentMember
42720
2025-04-01
2026-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
42720
2025-04-01
2026-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
42720
2026-03-31
42720
2026-03-31
jppfs_cor:CapitalStockMember
42720
2026-03-31
jppfs_cor:CapitalSurplusMember
42720
2026-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
42720
2026-03-31
jppfs_cor:NonControllingInterestsMember
42720
2026-03-31
jpcrp_cor:ReconcilingItemsMember
42720
2026-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
42720
2026-03-31
jpcrp_cor:ReportableSegmentsMember
42720
2026-03-31
jppfs_cor:RetainedEarningsMember
42720
2026-03-31
jppfs_cor:ShareholdersEquityMember
42720
2026-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
42720
2026-03-31
jppfs_cor:TreasuryStockMember
42720
2026-03-31
tse-acedjpfr-42720:FineChemicalsBusinessUnitReportableSegmentMember
42720
2026-03-31
tse-acedjpfr-42720:LifeScienceBusinessUnitReportableSegmentMember
42720
2026-03-31
tse-acedjpfr-42720:MobilityAndImagingBusinessUnitReportableSegmentMember
42720
2026-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
42720
2026-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
42720
2024-04-01
2025-03-31
42720
2024-04-01
2025-03-31
jppfs_cor:CapitalStockMember
42720
2024-04-01
2025-03-31
jppfs_cor:CapitalSurplusMember
42720
2024-04-01
2025-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
42720
2024-04-01
2025-03-31
jppfs_cor:NonControllingInterestsMember
42720
2024-04-01
2025-03-31
jpcrp_cor:ReconcilingItemsMember
42720
2024-04-01
2025-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
42720
2024-04-01
2025-03-31
jpcrp_cor:ReportableSegmentsMember
42720
2024-04-01
2025-03-31
jppfs_cor:RetainedEarningsMember
42720
2024-04-01
2025-03-31
jppfs_cor:ShareholdersEquityMember
42720
2024-04-01
2025-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
42720
2024-04-01
2025-03-31
jppfs_cor:TreasuryStockMember
42720
2024-04-01
2025-03-31
tse-acedjpfr-42720:FineChemicalsBusinessUnitReportableSegmentMember
42720
2024-04-01
2025-03-31
tse-acedjpfr-42720:LifeScienceBusinessUnitReportableSegmentMember
42720
2024-04-01
2025-03-31
tse-acedjpfr-42720:MobilityAndImagingBusinessUnitReportableSegmentMember
42720
2024-04-01
2025-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
42720
2024-04-01
2025-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
42720
2025-03-31
42720
2025-03-31
jppfs_cor:CapitalStockMember
42720
2025-03-31
jppfs_cor:CapitalSurplusMember
42720
2025-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
42720
2025-03-31
jppfs_cor:NonControllingInterestsMember
42720
2025-03-31
jpcrp_cor:ReconcilingItemsMember
42720
2025-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
42720
2025-03-31
jpcrp_cor:ReportableSegmentsMember
42720
2025-03-31
jppfs_cor:RetainedEarningsMember
42720
2025-03-31
jppfs_cor:ShareholdersEquityMember
42720
2025-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
42720
2025-03-31
jppfs_cor:TreasuryStockMember
42720
2025-03-31
tse-acedjpfr-42720:FineChemicalsBusinessUnitReportableSegmentMember
42720
2025-03-31
tse-acedjpfr-42720:LifeScienceBusinessUnitReportableSegmentMember
42720
2025-03-31
tse-acedjpfr-42720:MobilityAndImagingBusinessUnitReportableSegmentMember
42720
2025-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
42720
2025-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
42720
2024-03-31
42720
2024-03-31
jppfs_cor:CapitalStockMember
42720
2024-03-31
jppfs_cor:CapitalSurplusMember
42720
2024-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
42720
2024-03-31
jppfs_cor:NonControllingInterestsMember
42720
2024-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
42720
2024-03-31
jppfs_cor:RetainedEarningsMember
42720
2024-03-31
jppfs_cor:ShareholdersEquityMember
42720
2024-03-31
jppfs_cor:TreasuryStockMember
42720
2024-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
42720
2024-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
iso4217:JPY
xbrli:pure